Andrew Van Ostrand on GLP-1 Market Dynamics
Sirona Strategies Senior Vice President Andrew Van Ostrand was featured in Endpoints News discussing how compounded GLP-1 medications are influencing competition and pricing in the rapidly evolving weight-loss drug market. Van Ostrand brings deep experience at the intersection of telehealth, drug compounding, and health care policy, including previously leading government affairs at Hims & Hers […]